Female Reproductive System Carcinoma — Trials

Female Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,481 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 458
Recruiting: 230
Ph III recruiting: 25
Growth YoY: +35.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 201–202 of 202 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00673192	Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population	unknown	N/A	100	National Taiwan University HospitalOTHER	1	May 7, 2008	clinicaltrials
NCT00154986	IGFBP-3 in Ovarian Cancer Invasion	unknown	N/A	30	National Taiwan University HospitalOTHER	1	Sep 12, 2005	clinicaltrials